T
0.663
-0.05 (-7.18%)
| Previous Close | 0.714 |
| Open | 0.696 |
| Volume | 17,147,602 |
| Avg. Volume (3M) | 42,963,533 |
| Market Cap | 618,943,872 |
| Price / Sales | 0.500 |
| Price / Book | 0.180 |
| 52 Weeks Range | |
| Earnings Date | 8 Apr 2025 |
| Profit Margin | -30.02% |
| Operating Margin (TTM) | -15.30% |
| Diluted EPS (TTM) | -1.10 |
| Quarterly Revenue Growth (YOY) | 8.90% |
| Total Debt/Equity (MRQ) | 10.82% |
| Current Ratio (MRQ) | 2.54 |
| Operating Cash Flow (TTM) | -60.69 M |
| Levered Free Cash Flow (TTM) | -14.70 M |
| Return on Assets (TTM) | -1.45% |
| Return on Equity (TTM) | -7.02% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Tilray Brands, Inc. | Bearish | Bearish |
AIStockmoo Score
-0.1
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.13 |
|
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 0.65% |
| % Held by Institutions | 11.73% |
| 52 Weeks Range | ||
| Median | 1.00 (50.90%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 09 Apr 2025 | 1.00 (50.90%) | Hold | 0.530 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |